Sinopharm applies for vaccine market approval
chinadaily.com.cn |
Updated: 2020-11-25 14:29
Share
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- European students explore modern China through BFSU program
- From Belgium to studying Chinese medicine in Yunnan: I found my answer at the South Expo
- Shanghai Disneyland to open new immersive, interactive exhibition
- China's anti-drug efforts yield results, yet complex threats persist
- Shenzhou XX crew to conduct second spacewalk
- Annual science gathering set for Beijing next month
